Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 7, 2006
Grant Date -
Jul 3, 2003
app pub date -
Nov 22, 2002
filing date -
Aug 27, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is drawn to set of formulations of at least one compound selected from tolterodine, salts thereof, prodrugs thereof and/or metabolites thereof, wherein in the set of formulations contains at least one device for transdermal administration and at least one formulation for oral, sublingual, buccal, nasal, pulmonary, rectal and/or other transmucosal administration, in order to achieve an effect against overactive bladder and/or symptoms associated with this condition. The present invention is further drawn to methods of treating an overactive bladder with the formulations.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully